News and features

A new study has helped to uncover how bacterial proteins work as a network to take control of our cells.

A drug discovered at The Institute of Cancer Research that could counteract drug resistance in patients with cancers including acute myeloid leukaemia has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust.

Work has begun to create a new Innovation Gateway – a high-quality incubator space for life-science companies – at the heart of The London Cancer Hub in Sutton, south London.

The first proton beam therapy clinical trial in the UK, co-led by The Institute of Cancer Research, London, is now taking place at The Christie NHS Foundation Trust in Manchester.

A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.

Profiling the ‘immune landscape’ of patient’s tumours reveals who will most benefit from radiotherapy with potential immunotherapy in bowel cancer. Tumours which are chronically Inflamed before treatment could be made more susceptible using targeted immunotherapies

DNA damage is the basic cause of cancer, and understanding how cells repair DNA can help researchers develop the next generation of smarter, kinder treatments.

For the second virtual event, Discovery Club members went on a trip back in time and deep inside the cell with Professor Jessica Downs and Dr Navita Somaiah to explore how targeting cancer’s DNA weaknesses can unlock new treatments.

A type of ultrasound scan can detect cancer tissue left behind after a brain tumour is removed more sensitively than surgeons, and could improve the outcome from operations, a new study suggests.

Six outstanding images have been shortlisted for the ICR’s Science and Medical Imaging competition. Over the next two weeks, we will be sharing our shortlist across the ICR’s social media channels and on our website for a public vote, before we announce the judge’s chosen winner and the public’s choice.

Twenty years ago, a detailed draft and analysis of the human genome was completed. In this feature, Diana Cano Bordajandi looks at the lasting legacy of the Human Genome Project.

Men who have had treatment for early stage testicular cancer could benefit from fewer monitoring scans, freeing them from some of the harmful radiation that comes from computerized tomography (CT) imaging, according to results presented at GU ASCO conference.